Glycomine
0 followers
‌
Glycomine is developing orphan drugs for serious rare disorders of metabolism and protein misfolding for which no other therapeutic options exist.
Industries
Headquarters
Employees
Links
Org chart
Steven Axon
Director & CEO
Steven Axon
Collapse
Hicham Alaoui
Chief Scientific Officer
Geoffrey Hird
Chief Technology Officer
Peter McWilliams
Chief Business Officer
Kerryn Mccluskie
VP, Non-clinical Development
Lisa Koch-Hulle
Acting VP, Regulatory Affairs
Drew Folk
Sr. Director Of Product Development
Emily Tess
Chief of Staff, Director of Corporate Development & Strategy
Kevin Herlihy
Sr. Director Manufacturing Science And Technology
Colette Muenzen
Senior Legal Consultant
Rose Marino
Chief Medical Officer
